[1] Amodio P, Bemeur C, Butterworth R, et al. The Nutritional Management of Hepatic Encephalopathy in Patients With Cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology, 2013, 58:325-336.
[2] 中华医学会消化病学分会,中华医学会肝病学分会,中国肝性脑病诊治公式意见(2013年,重庆).中华肝脏病杂志,2013,21:641-651.
[3] Tandon P, Raman M, Mourtzakis M, et al. A practical approach to nutritional screening and assessment in cirrhosis. Hepatology, 2017, 65:1044-1057.
[4] 朱鸣,赵长青,平键,等.人体测量学指标在肝硬化病人营养风险评估中的意义.肠外与肠内营养,2016,23:8-11.
[5] Bharadwaj S, Ginoya S, Tandon P, et al. Malnutrition: laboratory markers vs nutritional assessment. Gastroenterol Rep (Oxf), 2016, 4:272-280.
[6] Gao W, Kong M, Yao J, et al. Changes in prealbumin and body mass index associated with T lymphocyte subsets and nutritional status in chronic hepatitis b and hbv-cirrhosis patients. Clin Lab, 2018, 64.
[7] Sengupta S, Wroblewski K, Aronsohn A, et al. Screening for zinc deficiency in patients with cirrhosis: When should we start? Dig Dis Sci, 2015, 60:3130-3135.
[8] Weston J. B, Jason P. D, Mary A. M, et al. Computed tomography measures of nutrition in patients with end-stage liver disease provide a novel approach to characterize deficits. Transplant Proc, 2018, 50:3501-3507.
[9] Shen W, Punyanitya M, Wang Z, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image.J Appl Physiol (1985), 2004, 97:2333-2338.
[10] Tandon P, Low G, Mourtzakis M, et al. A model to identify sarcopenia in patients with cirrhosis. Clin Gastroenterol Hepatol, 2016, 14:1473-1480.e3.
[11] Moctezuma-Velázquez C, García-Juárez I, Soto-Solís R, et al. Nutritional assessment and treatment of patients with liver cirrhosis. Nutrition, 2013,29:1279-1285.
[12] Fernandes SA, de Mattos AA, Tovo CV, et al. Nutritional evaluation in cirrhosis: emphasis on the phase angle. World J Hepatol, 2016, 8:1205-1211.
[13] Giusto M, Lattanzi B, Albanese C, et al. Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry. Eur J Gastroenterol Hepatol, 2015, 27:328-334.
[14] Tandon P, Tangri N, Thomas L, et al. A rapid bedside screen to predict unplanned hospitalization and death in outpatients with cirrhosis: a prospective study of the clinical frailty scale.Am J Gastroenterol, 2016, 111:1759-1767.
[15] Ney M, Haykowsky M, Vandermeer B, et al. Systematic review: pre- and post-operative prognostic value of cardiopul-monary exercise testing in liver transplant candidates.Aliment Pharmacol Ther, 2016, 44:796-806.
[16] 时淑云, 韩军军, 闫茗, 等.慢性肝病患者的营养风险评估. 中华肝脏病杂志,2014,22:536-539.
[17] da Silva Fink J, Daniel de Mello P, Daniel de Mello E. Subjective global assessment of nutritional status-A systematic review of the literature. Clin Nutr, 2015, 34:785-792.
[18] Morgan MY, Madden AM, Soulsby CT, et al. Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis. Hepatology, 2006, 44:823-835.
[19] Arora S, Mattina C, Catherine M, et al. The development and validation of a nutritional prioritizing tool for use in patients with chronic liver disease. Gut,2012, 61(Suppl 2):A90.
[20] Borhofen SM, Gerner C, Lehmann J, et al. The Royal Free Hospital-Nutritional Prioritizing Tool Is an Independent Predictor of Deterioration of Liver Function and Survival in Cirrhosis. Dig Dis Sci, 2016, 61:1735-1743. |
